About one in four Veterans lives with type 2 diabetes (T2D) , and nationwide, only 50% of Veterans meet the ADA glycemic target of A1c <7%. In a pilot program, the Veterans Health Administration partnered with Virta Health to deliver carbohydrate restricted nutrition therapy via a continuous remote care model to Veterans with T2D prescribed at least one diabetes medication other than metformin. This retrospective, real-world, descriptive study assessed the proportion of Veterans who met glycemic targets using laboratory and prescription data from medical records. Veterans retained in the treatment at least two years at time of analysis were included (n=254, 58.5% of 434 eligible enrolled, 60±8 years, 12% female, 50% above HEDIS target) . A greater percentage of Veterans met glycemic targets defined by AACE (A1c ≤ 6.5%) , ADA (A1c < 7%) , and HEDIS (A1c < 8%) following one and two years of treatment compared to enrollment (Table 1) . About two thirds of Veterans with A1c ≤6.5% achieved this with no medication or only metformin. Further, 6.7% and 4.5% achieved the 2021 consensus definition of remission at one and two years, respectively. These findings suggest this nutrition therapy and care model may be a useful tool to improve population health among Veterans with respect to glycemic targets.
A.L.Mckenzie: Employee; Virta Health Corp., Stock/Shareholder; Virta Health Corp. M.Vantieghem: Employee; Virta Health Corp., Stock/Shareholder; Virta Health Corp. B.Fell: Employee; Virta Health Corp., Stock/Shareholder; Virta Health Corp. R.E.Ratner: Employee; Virta Health Corp.